๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis

โœ Scribed by Nabeetha A. Nagalingam; John Y. Kao; Vincent B. Young


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
460 KB
Volume
17
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

โœฆ Synopsis


Background: Dextran sodium sulfate (DSS) is used to induce murine colitis. Although the exact mechanism by which DSS administration causes disease is unknown, evidence suggests that the resident bacteria play a role in the development of murine DSS colitis, analogous to their role in human inflammatory bowel diseases.

Methods: C57BL/6 mice received 5% DSS in the drinking water and were euthanized 3 days and 14 days after the initiation of DSS treatment. Culture-independent methods were used to follow changes in the community structure of the gut's microbiota following DSS treatment. Histologic evidence of disease and changes in host gene expression were assessed.

Results: Histologic colitis was minimal in DSS-treated animals at 3 days, but severe after 14 days. Analysis of 16S rRNA-encoding gene clone libraries demonstrated that the microbial communities in the ceca of DSS-treated mice were distinct from those in control mice. The microbiota in the cecum of DSS-treated animals was characterized by an overall decrease in microbial richness, an increase in members of the phylum Verrucomicrobia, and decrease in Tenericutes. Changes in the host's inflammatory response and microbial communities occurred before the histologic appearance of severe disease in the colon, but were seen concurrently in the cecum.

Conclusions: DSS administration is associated with reproducible changes in the gut microbial diversity of mice. Microbial and immunological changes appeared before the development of severe inflammation in the colon. This indicates that these changes in microbial community may play role in the potentiation of the abnormal inflammatory response seen in DSS-treated animals.


๐Ÿ“œ SIMILAR VOLUMES


5-aminosalicylic acid inhibits colitis-a
โœ Margie L. Clapper; Monique A. Gary; Renata A. Coudry; Samuel Litwin; Wen-Chi L. ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 304 KB

## Background: The impact of the antiinflammatory agent 5-aminosalicylic acid (5-ASA) on the risk for colitis-associated colorectal cancer remains controversial. The chemopreventive activity of 5-ASA was evaluated in the Swiss Webster model of azoxymethane (AOM)/dextran sulfate sodium (DSS)-induce

Biochemical and histological changes in
โœ Roger Yazbeck; Gordon S. Howarth; Ross N. Butler; Mark S. Geier; Catherine A. Ab ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 218 KB

The dextran sulfate sodium (DSS) model of colitis has been commonly utilized in mice to assess novel treatments for ulcerative colitis. Recent studies have indicated that morphological and biochemical changes extend to the small intestine (SI). This study aimed to characterize histological and bioch